	TDP-43: a critical amplifier of Alzheimer's disease beyond amyloid and tau. Neuroscience Roy A, Chhetry S, Deka H, Roy R, Bhattacharya P, Patel BK, Borah A. PMID: 42167675 [PubMed - as supplied by publisher]
	A hybrid CNN-GCN framework for interpretable Alzheimer's disease diagnosis from MRI scans. Neuroscience Islam J, Lin FY, Lin CY. PMID: 42167674 [PubMed - as supplied by publisher]
	Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0. Nuklearmedizin Barthel H, Brendel M, Albert N, Boecker H, Bouter C, Brumberg J, Buchert R, La Fougère C, Gründer G, Hesse S, Kuwert T, Lange C, Langen KJ, Lohmann P, Meyer PT, Miederer I, Neumaier B, Rominger A, Schreckenberger M, Schulz JB, Yakushev I, Drzezga A. PMID: 42167288 [PubMed - indexed for MEDLINE]
	AI-assisted integrative framework combining microarray data analysis and cerebrospinal fluid pharmacology for revealing molecular mechanism in Alzheimer's disease: A case study of Psoraleae Fructus. J Pharm Biomed Anal Li X, Qi J, Pan F, Zhang Y, Wang L, Yi Z, Liu H, Zheng J, Pan Y, Liu F, Jiang L, Chen S. PMID: 42166920 [PubMed - as supplied by publisher]
	From DNA repair to neurodegeneration: PARP1 mechanisms and inhibitor strategies in Alzheimer's disease. DNA Repair (Amst) Banjare P, Patel R. PMID: 42166869 [PubMed - as supplied by publisher]
	Progressive myoclonus epilepsy in Down syndrome with Alzheimer's disease: An 11-year longitudinal study and proposed diagnostic red flags. Epilepsia Open d'Orsi G, Calò E, Di Claudio MT, Ferro CP, Costantino U, Perrone E, Latino RR. PMID: 42166529 [PubMed - as supplied by publisher]
	Prediction of cognitive impairment through speech data analysis: A comparative evaluation of deep learning models. PLoS One Kim M, Choi H, Shim Y, Ryoo N, Jeong HT, Yun G, Lee H, Kim S, Youn YC. PMID: 42166472 [PubMed - indexed for MEDLINE]
	Mechanistic insights into mesenchymal stem cell therapy for cognitive impairments in Alzheimer's disease models: a systematic review and meta-analysis. Mol Cell Biochem Kariminejad-Farsangi H, Kariminejad-Farsangi H, Mir Y, Sheibani V, Joushi S. PMID: 42166005 [PubMed - as supplied by publisher]
	Novel salivary biomarkers of Alzheimer's disease identified by integrated metabolomics and microbiomics analysis. Clin Oral Investig Chen H, Chen H, Xie L, Jiang K, Xia E, Mao J, Liu Z, Li X, Xiao Y, Qian X, Jin Z. PMID: 42165911 [PubMed - indexed for MEDLINE]
	2-aminobutyrate mediates the impact of air pollution on blood biomarkers of Alzheimer's disease. Alzheimers Dement Saeed A, Mckennan C, Clougherty JE, Zhou P, Tripathy S, Kinnee EJ, Duan J, Kip K, Zeng X, Villemagne V, Pascoal T, Mapstone M, Whitsel EA, Lopez OI, Ballantyne C, Karikari TK, Yu B, Reis S, Cohen A. PMID: 42165338 [PubMed - indexed for MEDLINE]
	Artificial intelligence for detection and staging of Alzheimer's disease using retinal images. Cochrane Database Syst Rev Panjwani M, Holmes JM, Liu SH, Lee E, Rapcsak S, Harris A, Kozak I. PMID: 42165286 [PubMed - indexed for MEDLINE]
	Toward nanomedicine-enabled RNA therapeutics for Alzheimer's disease. Mol Neurodegener Adv Kara G, Villapol S. PMID: 42164918 [PubMed]
	2DSDNN: A Novel Approach for Alzheimer's Disease Classification. Curr Med Imaging Malik P, Singh S. PMID: 42163688 [PubMed - as supplied by publisher]
	An Investigation of the Neurotoxic Mechanisms of Benzo[a]pyrene in Alzheimer's Disease Using an Integrated Approach of Network Toxicology and Machine Learning. Curr Neuropharmacol Jin S, Liu D, Ouyang J. PMID: 42163678 [PubMed - as supplied by publisher]
	predALZ: An Ensemble Learning Framework for Identifying Genetic Biomarkers in Familial Alzheimer's Disease. Curr Drug Targets Karim A, Alturise F, Alkhalifah T, Khan YD. PMID: 42163597 [PubMed - as supplied by publisher]
	A clinically feasible framework to estimate tau pathology and clinical-biological discordance in the Alzheimer's disease spectrum. Alzheimers Res Ther Hsu JL, Huang SY, Wu HC, Lin KJ, Huang KL, Huang CC, Kim S, Hsiao IT. PMID: 42163384 [PubMed - as supplied by publisher]
	Unawareness of deficits in mild cognitive impairment: a systematic review of its role in progression to Alzheimer's disease. BMC Neurol Moore L, Lund AE, Russell C. PMID: 42163170 [PubMed - as supplied by publisher]
	Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's disease and Parkinson's disease using polygenic risk scores and Mendelian randomization. Alzheimers Dement Chatterjee A, Alvarez B, Sharma RU, Jonson C, Wilkins HM, Pa J, Swerdlow RH, Goate A, Yaffe K, Andrews SJ, Alzheimer's Disease Genetics Consortium and the Alzheimer's Disease Neuroimaging Initiative. PMID: 42163007 [PubMed - indexed for MEDLINE]
	The clinical Alzheimer's disease spectrum classified in the A/T/N framework with (18)F-Flutemetamol-Centiloid, (18)F-MK-6240-CenTauR, and (18)F-FDG-AD metaROI: a multicenter memory clinic observational study. Eur J Nucl Med Mol Imaging Megens VR, Strandhagen PW, Berntsen EM, Müller EG, Van Laere K, Eikenes L, Haberg AK, 180. PMID: 42162446 [PubMed - as supplied by publisher]
	From mechanistic modeling to AI-driven design: computational strategies for targeting the Î³-secretase complex. Brief Bioinform Das S, Rao Padubidri S, K V S, Shetty KS, Jena R, K R H, Dehury B, Pandurangan AP. PMID: 42160739 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 70492

Page 1 of 3525



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy